A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis

BACKGROUND: Although individualized dosage regimens for anti-hepatitis B immunoglobulin (HBIG) therapy have been suggested, the pharmacokinetic profile and factors influencing the basis for individualization have not been sufficiently assessed. We sought to evaluate the pharmacokinetic characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Seunghoon, Na, Gun Hyung, Kim, Dong-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513836/
https://www.ncbi.nlm.nih.gov/pubmed/28744101
http://dx.doi.org/10.2147/DDDT.S134711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513836/
https://www.ncbi.nlm.nih.gov/pubmed/28744101
http://dx.doi.org/10.2147/DDDT.S134711

Ejemplares similares